{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:10:42Z","timestamp":1780791042360,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The relationship between dyslipidemia and female reproductive endocrine diseases has been increasingly studied. The use of lipid-lowering drugs in treating various related diseases, including coronary heart disease, may affect female reproductive endocrine diseases. Therefore, our study aims to investigate the effects of lipid-lowering drugs on female reproductive endocrine diseases and provide a basis for the appropriate selection of drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we focused on three drug targets of statins, namely HMG-CoA reductase (HMGCR) inhibitors, proprotein convertase kexin 9 (PCSK9) inhibitors, and Niemann\u2013Pick C1-Like 1 (NPC1L1) inhibitors. To identify potential inhibitors for these targets, we collected single nucleotide polymorphisms (SNPs) associated with HMGCR, PCSK9, and NPC1L1 from published genome-wide association study statistics. Subsequently, we conducted a drug target Mendelian randomization (MR) analysis to investigate the effects of these inhibitors on reproductive endocrine diseases mediated by low-density lipoprotein cholesterol (LDL-C) levels. Alongside coronary heart disease as a positive control, our main outcomes of interest included the risk of polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), premenstrual syndrome (PMS), abnormal uterine bleeding (including menorrhagia and oligomenorrhea), and infertility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PCSK9 inhibitors significantly increased the risk of infertility in patients (OR [95%CI] = 1.14 [1.06, 1.23], p&amp;lt;0.05). In contrast, HMGCR inhibitors significantly reduced the risk of menorrhagia in female patients (OR [95%CI] = 0.85 [0.75, 0.97], p&amp;lt;0.05), but had no statistical impact on patients with oligomenorrhea.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings suggest that PCSK9 inhibitors may significantly increase the risk of infertility in patients. On the other hand, HMGCR inhibitors could potentially offer protection against menorrhagia in women. However, no effects of lipid-lowering drugs have been observed on other reproductive endocrine disorders, such as PCOS, POF, PMS and oligomenorrhea.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1295412","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:57:58Z","timestamp":1699876678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Causal association between lipid-lowering drugs and female reproductive endocrine diseases: a drug-targeted Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/1841082a0","article-title":"Site of production of oestrogen in the ovary of the rat","volume":"184","author":"Falck","year":"1959","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/0960327119865588","article-title":"Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide-induced premature ovarian failure in female albino mice","volume":"38","author":"Elkady","year":"2019","journal-title":"Hum Exp Toxicol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/00016349309021108","article-title":"Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids","volume":"72","author":"Cerin","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B4","article-title":"Relationship of uterine fibroids with lipid profile, anthropometric characteristics, subcutaneous and preperitoneal fat thickness","volume":"22","author":"Sharami","year":"2019","journal-title":"Arch Iran Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/nu15143130","article-title":"The association between circulating lipids and female infertility risk: a univariable and multivariable mendelian randomization analysis","volume":"15","author":"Zhu","year":"2023","journal-title":"Nutrients"},{"key":"B6","doi-asserted-by":"publisher","first-page":"Cd008565","DOI":"10.1002\/14651858.CD008565.pub2","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fertnstert.2009.01.158","article-title":"Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome","volume":"94","author":"Xu","year":"2010","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s11658-019-0194-5","article-title":"Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter","volume":"24","author":"Meng","year":"2019","journal-title":"Cell Mol Biol Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.111.098806","article-title":"Simvastatin decreases invasiveness of human endometrial stromal cells","volume":"87","author":"Sokalska","year":"2012","journal-title":"Biol Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-coA reductase inhibition and cognitive function","volume":"80","author":"Rosoff","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.08.015","article-title":"Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia","volume":"186","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunningham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.11.006","article-title":"Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome","volume":"644","author":"Xavier","year":"2018","journal-title":"Gene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-1028-6","article-title":"PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl\/Bax-caspase9-caspase3 pathway","volume":"359","author":"Wu","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003410","article-title":"Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study","volume":"17","author":"Rosoff","year":"2020","journal-title":"PloS Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-012110-142233","article-title":"Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport","volume":"73","author":"Jia","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-071714-034338","article-title":"New insights into the regulation of chylomicron production","volume":"35","author":"Dash","year":"2015","journal-title":"Annu Rev Nutr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.9b05221","article-title":"Xanthohumol suppresses NPC1L1 gene expression through downregulation of HNF-4\u03b1 and inhibits cholesterol uptake in caco-2 cells","volume":"67","author":"Thang","year":"2019","journal-title":"J Agric Food Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0107-8","article-title":"PCSK9 inhibitors: clinical evidence and implementation","volume":"16","author":"Sabatine","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25642","article-title":"Lipid lowering and Alzheimer disease risk: A mendelian randomization study","volume":"87","author":"Williams","year":"2020","journal-title":"Ann Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310605","article-title":"Mendelian randomisation in cardiovascular research: an introduction for clinicians","volume":"103","author":"Bennett","year":"2017","journal-title":"Heart"},{"key":"B27","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/127226","article-title":"PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study","volume":"17","author":"Lyall","year":"2021","journal-title":"Arch Med Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn217","article-title":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research","volume":"168","author":"Knol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz160","article-title":"Using a two-sample Mendelian randomization design to investigate a possible causal effect of maternal lipid concentrations on offspring birth weight","volume":"48","author":"Hwang","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/art.42304","article-title":"Telomere length and development of systemic lupus erythematosus: a mendelian randomization study","volume":"74","author":"Wang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B40","article-title":"The effect of endocrine disorders on lipids and lipoproteins","author":"Feingold","year":"2023"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-37501","article-title":"Statins can inhibit proliferation of human breast cancer cells in vitro","volume":"111","author":"Seeger","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2407-10-103","article-title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance","volume":"10","author":"Martirosyan","year":"2010","journal-title":"BMC Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23593","article-title":"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice","volume":"123","author":"Cho","year":"2008","journal-title":"Int J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.06.036","article-title":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","volume":"215","author":"Borahay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13248","article-title":"Optimal low-density lipoprotein concentration for cardiac allograft vasculopathy prevention","volume":"32","author":"Harris","year":"2018","journal-title":"Clin Transplant"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz313","article-title":"PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1","volume":"116","author":"Ding","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis","author":"Izquierdo","year":"2004","journal-title":"Fertil Steril"},{"key":"B51","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","article-title":"Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial","volume":"85","author":"Duleba","year":"2006","journal-title":"Fertil Steril"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1295412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:58:03Z","timestamp":1699876683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1295412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":52,"alternative-id":["10.3389\/fendo.2023.1295412"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1295412","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"article-number":"1295412"}}